Loading…
Underlying
Underlying Price
$185.04
Type
Call
Strike
164
Expiration
Dec 4, 2026
DTE
33d
Moneyness
ITM
Intrinsic
$21.04
XLV 164 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 30, 2026 | -2d | $16.77 | +7.16% | 1 | 1 |
| Nov 6, 2026 | 5d | — | — | 0 | 0 |
| Nov 13, 2026 | 12d | — | — | 0 | 0 |
| Nov 20, 2026 | 19d | $8.95 | +32.20% | 50 | 64 |
| Nov 27, 2026 | 26d | — | — | 0 | 0 |
| Dec 4, 2026 | 33d | — | — | 0 | 0 |
| Dec 18, 2026 | 47d | $16.45 | +64.50% | 1 | 94 |
| Jan 15, 2027 | 75d | $15.50 | +33.05% | 1 | 239 |
| Mar 19, 2027 | 138d | $20.65 | +56.44% | 10 | 38 |
| Jun 17, 2027 | 228d | $23.75 | +93.88% | 2 | 12 |
| Jan 19, 2029 | 810d | $29.88 | +21.71% | 1 | 5 |
XLV Profile
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.